A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00675623. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global Phase 3, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Oral Dimebon in Patients With Mild-to-Moderate Alzheimer's Disease (CONNECTION)
Study identification
- NCT ID
- NCT00675623
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Medivation, Inc.
- Industry
- Enrollment
- 598 participants
Conditions and interventions
Conditions
Interventions
- Dimebon Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- Nov 30, 2009
- Completion
- Not listed
- Last update posted
- Sep 26, 2016
Started 2008
United States locations
- U.S. sites
- 28
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85004 | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Fresno | California | 93720 | — |
| Not listed | Rancho Mirage | California | — | — |
| Not listed | Hamden | Connecticut | — | — |
| Not listed | New Haven | Connecticut | — | — |
| Not listed | Norwalk | Connecticut | — | — |
| Not listed | Hallandale | Florida | 33009 | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Miami | Florida | 33137 | — |
| Not listed | North Miami | Florida | 33161 | — |
| Not listed | Sunrise | Florida | 33351 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Paducah | Kentucky | 42003 | — |
| Not listed | Newton | Massachusetts | 02459 | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | St Louis | Missouri | 63044 | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Cedarhurst | New York | 11516 | — |
| Not listed | New York | New York | — | — |
| Not listed | Rochester | New York | 14620 | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Morganton | North Carolina | 28655 | — |
| Not listed | Centerville | Ohio | — | — |
| Not listed | Norristown | Pennsylvania | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00675623, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 26, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00675623 live on ClinicalTrials.gov.